시장보고서

상품코드

1629231

세계의 정맥내(IV) 수분 보급 요법 시장 : 성분별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측(2025-2032년)

Intravenous (IV) Hydration Therapy Market, By Component, By Application, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2024년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 390 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

정맥내(IV) 수분 보급 요법 시장 규모는 2024년에 26억 7,825만 달러에 달하며, 2025-2032년에 CAGR 8.1%로 확대

정맥내(IV) 수분 보급 요법 시장 역학

탈수 관련 질환의 유병률 증가가 시장 성장을 주도하고 있습니다.

탈수증 관련 유병률 증가는 정맥내 수액 요법 시장의 성장을 가속하는 중요한 요인입니다. 탈수증은 과도한 더위, 질병, 영양실조, 치열한 운동 등 다양한 요인으로 인해 발생할 수 있으며, 신부전, 열사병, 전해질 불균형과 같은 심각한 합병증을 유발할 수 있습니다. 기후 변화, 기온 상승, 폭염 빈도 증가와 같은 세계 건강 문제로 인해 탈수증은 특히 노인, 어린이, 만성질환자 등 취약한 집단에서 더욱 흔하게 발생하고 있습니다. 환경적 요인 외에도 위장염, 당뇨병, 만성 신장질환과 같은 질병이 탈수율 증가에 기여하고 있으며, 효과적인 수분 보충 요법의 필요성이 더욱 커지고 있습니다. 수액 주입을 통한 수분 보충 요법은 응급의료 현장에서 필수적이며, 신속한 수분과 전해질 보충은 추가적인 합병증을 예방하는 데 매우 중요합니다. 세계보건기구(WHO)에 따르면 탈수는 연간 130만 명의 사망을 유발하며, 그 대부분은 중저소득 국가에서 발생합니다. 수분 보충 요법의 중요성에 대한 인식이 높아지고, 보다 진보된 정맥내 수분 공급 솔루션의 가용성이 시장 확대의 원동력이 될 것으로 예상됩니다.

정맥 내(IV) 수액 요법 시장 : 주요 고려사항

당사의 리서치 애널리스트들의 분석에 따르면 세계 시장은 예측 기간(2025-2032년) 동안 연평균 약 8.1%%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.
성분별로는 약용이 2024년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
최종 용도별로는 2024년 병원이 주요 기능이었습니다.
지역별로는 북미가 2024년 매출을 창출할 주요 시장입니다.

정맥 내(IV) 수액 요법 시장 : 세분화 분석

정맥내(IV) 수분 보급 요법 세계 시장은 성분, 용도, 최종 용도 및 지역에 따라 분류됩니다.

시장은 성분에 따라 약용과 비약용의 두 가지 범주로 나뉩니다. 약용 요법은 전해질 불균형, 감염, 영양실조와 같은 특정 질환을 치료할 수 있는 능력과 표적화된 치료 효과를 제공하므로 시장을 독점하고 있습니다. 중환자 치료 환경에서의 효과로 인해 의료진들 사이에서 높은 수요와 선호도를 확보하고 있습니다.

시장은 최종사용자별로 병원, 웰니스 센터/스파, 재택의료의 세 가지로 분류됩니다. 병원은 신속한 수분 공급이 환자의 안정화에 필수적인 응급의료 및 집중치료의 중심 역할을 담당하고 있으며, 시장을 독점하고 있습니다. 또한 병원은 특수한 수분 보충 치료를 효과적으로 수행할 수 있는 인프라와 자원을 보유하고 있습니다.

정맥 내(IV) 수액 요법 시장 : 지역별 분석

북미는 첨단 의료 시설, 응급 및 구급 의료에 대한 높은 수요, 정맥내 수액 요법의 장점에 대한 인식이 널리 퍼져 있으며, 압도적인 점유율을 차지하고 있습니다. 특히 미국에서는 열사병, 독감, 위장 장애 등 다양한 증상으로 인한 탈수 증상 관리 등 의료 및 건강 목적으로 정맥내 수액 공급의 사용이 증가하고 있습니다. 유럽에서는 독일, 영국 등 의료 선진국들이 환자 치료에 정맥 수액 요법을 채택하는 병원이 증가함에 따라 시장이 꾸준히 성장하고 있습니다. 아시아태평양, 특히 인도와 중국은 의료 시스템 개선, 도시화, 만성질환 유병률 증가로 인해 빠르게 성장하고 있으며, 이는 수액요법에 대한 수요 증가로 이어지고 있습니다. 라틴아메리카와 중동도 의료 접근성 개선과 탈수 치료에서 정맥내 수분의 역할에 대한 인식이 높아짐에 따라 성장세를 보이고 있습니다.

정맥 내(IV) 수액 요법 시장 : 경쟁 구도

정맥 내(IV) 수액 치료 시장의 경쟁 환경은 기존 제약사부터 의료 솔루션 전문 스타트업까지 여러 주요 업체들의 존재로 특징지어집니다. 각 기업은 전략적 파트너십, 합병, 인수, 제휴를 통해 제품 라인업을 강화하고 시장을 확대하는 데 주력하고 있습니다. 대형 제약사 외에도 수액 보충 서비스 전문 업체들이 인기를 끌고 있으며, 특히 웰니스 및 외래 환자를 대상으로 소비자에게 직접 서비스를 제공합니다. 이러한 서비스는 숙취 해소, 운동 능력 향상 등 비의료적 목적으로 수분 보충 요법을 원하는 사람들에게 선호되고 있습니다. 또한 스마트 주입 펌프와 수액 제제 개선 등 수액 기술의 발전도 경쟁의 원동력이 되고 있습니다. 각 업체들은 또한 특정 질환에 맞는 보다 효과적이고 전문적인 수액 솔루션을 개발하기 위해 연구개발에 투자하고 있으며, 이는 시장 경쟁을 더욱 촉진하고 있습니다. 특히 의료 환경에서는 시장이 엄격하게 규제되고 있으므로 기업이 경쟁력을 유지하기 위해서는 규제 당국의 승인과 업계 표준을 준수하는 것이 필수적입니다. 의료 수요 증가, 인지도 향상, 기술 혁신 등의 요인으로 인해 정맥내 수액 요법에 대한 수요가 증가함에 따라 기업은 혁신적인 기술을 개발하고 진화하는 시장 동향에 적응해야 하는 경쟁 환경이 조성되고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 : 정맥내(IV) 수분 보급 요법 업계

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 개요
- Baxter International
- Fresenius Kabi
- B. Braun Melsungen AG
- Pfizer company
- Otsuka Pharmaceutical
- Terumo Corporation
- Medline Industries
- Sagent Pharmaceuticals
- Amgen
- Vifor Pharma
- ICU Medical
- Chugai Pharmaceutical
- Cipla
- Zhejiang Hisun Pharmaceutical
- Viatris
- Others

제12장 AnalystView의 전방위적 분석

KSA 25.02.13

REPORT HIGHLIGHT

Intravenous (IV) Hydration Therapy Market size was valued at US$ 2,678.25 Million in 2024, expanding at a CAGR of 8.1% from 2025 to 2032.

Intravenous (IV) hydration therapy involves the administration of fluids directly into a patient's bloodstream through an IV line. This method ensures rapid delivery of fluids, electrolytes, and nutrients, bypassing the digestive system for immediate absorption. IV hydration therapy is commonly used in medical settings to treat dehydration caused by conditions like vomiting, diarrhea, fever, or excessive heat exposure. It is also vital for patients recovering from surgery, illnesses, or those with chronic conditions that impair fluid absorption. The need for IV hydration therapy arises when the body cannot adequately absorb or retain fluids orally, or when rapid rehydration is necessary. It is crucial in situations where oral hydration is not effective or feasible, such as in cases of severe dehydration or electrolyte imbalances. By replenishing lost fluids and electrolytes, IV hydration helps restore normal body functions, ensuring proper circulation, temperature regulation, and nutrient transport. The importance of IV hydration therapy lies in its ability to stabilize critical patients quickly and efficiently. It prevents complications such as kidney failure, shock, and organ dysfunction that can arise from severe dehydration. Additionally, IV therapy supports recovery and enhances overall well-being, especially in emergency care, post-operative recovery, and intensive care units.

Intravenous (IV) Hydration Therapy Market- Market Dynamics

Rising Prevalence of dehydration-related conditions to drive the market growth

The rising prevalence of dehydration-related conditions is a significant driver for the growth of the IV hydration therapy market. Dehydration can result from various factors, including excessive heat, illness, malnutrition, or intense physical activity, and can lead to severe complications such as kidney failure, heat stroke, and electrolyte imbalances. With global health challenges like climate change, rising temperatures, and the increasing frequency of heatwaves, dehydration has become more common, particularly in vulnerable populations like the elderly, children, and those with chronic illnesses. In addition to environmental factors, conditions such as gastroenteritis, diabetes, and chronic kidney disease contribute to higher dehydration rates, further increasing the need for effective hydration therapies. IV hydration therapy is essential in emergency care settings, where rapid fluid and electrolyte replenishment are critical to preventing further complications. According to the World Health Organization (WHO), dehydration is responsible for 1.3 million deaths annually, with a large percentage of these deaths occurring in low- and middle-income countries. The growing awareness of the importance of rehydration therapies and the availability of more advanced IV hydration solutions are expected to drive the market's expansion.

Intravenous (IV) Hydration Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2025-2032)
Based on Component segmentation, Medicated was predicted to show maximum market share in the year 2024
Based on End-Use segmentation, Hospitals was the leading Function in 2024
On the basis of region, North America was the leading revenue generator in 2024

Intravenous (IV) Hydration Therapy Market- Segmentation Analysis:

The Global Intravenous (IV) Hydration Therapy Market is segmented on the basis of Component, Application, End-Use and Region.

The market is divided into five categories based on Component: Medicated and Non-Medicated. Medicated dominate the market due to their ability to treat specific medical conditions, such as electrolyte imbalances, infections, and malnutrition, offering targeted therapeutic benefits. Their effectiveness in critical care settings ensures higher demand and preference among healthcare providers.

The market is divided into three categories based on End-Use: Hospitals, Wellness Centres & Spas, and Home Healthcare. Hospitals dominate the market due to their central role in providing emergency and intensive care, where rapid rehydration is crucial for patient stabilization. Additionally, hospitals have the infrastructure and resources to administer specialized hydration treatments effectively.

Intravenous (IV) Hydration Therapy Market- Geographical Insights

North America holds a dominant share due to advanced healthcare facilities, high demand for emergency and critical care services, and widespread awareness about the benefits of IV hydration therapy. The U.S., in particular, has seen an increase in the use of IV hydration for medical and wellness purposes, including for managing dehydration from various conditions like heat stroke, flu, and gastrointestinal issues.In Europe, the market is growing steadily, with countries like Germany and the UK leading in healthcare advancements and a rising number of hospitals adopting IV hydration therapy for patient care. The Asia-Pacific region, particularly India and China, is experiencing rapid growth due to improving healthcare systems, rising urbanization, and an increasing prevalence of chronic diseases, leading to higher demand for hydration therapies. Latin America and the Middle East are also witnessing growth, driven by improvements in healthcare access and rising awareness of IV hydration's role in treating dehydration.

Intravenous (IV) Hydration Therapy Market- Competitive Landscape:

The competitive landscape of the intravenous (IV) hydration therapy market is characterized by the presence of several key players, ranging from established pharmaceutical companies to emerging startups specializing in healthcare solutions. Companies are focusing on strategic partnerships, mergers, acquisitions, and collaborations to enhance their product offerings and expand their market reach. In addition to large pharmaceutical firms, specialized providers of IV hydration services are gaining popularity, offering services directly to consumers, particularly in wellness and outpatient settings. These services are gaining traction as people seek hydration therapies for non-medical purposes, such as hangover recovery or athletic performance enhancement. Furthermore, advancements in IV infusion technologies, such as smart infusion pumps and improved fluid formulations, are contributing to the competitive dynamics. Companies are also investing in research and development to create more effective and specialized hydration solutions tailored to specific medical conditions, further fueling market competition. Regulatory approvals and compliance with industry standards are essential for companies to maintain a competitive edge, as the market is heavily regulated, particularly in healthcare settings. The increasing demand for IV hydration therapy, driven by factors like rising healthcare needs, growing awareness, and technological innovations, has resulted in a competitive environment where companies must innovate and adapt to evolving market trends.

Recent Developments:

In April 2024, Evocus launched its new hydration product, Evocus Hydration IV, designed to offer rapid water balance and enhanced performance with its unique Active Absorption Technology. This electrolyte drink mix, free from artificial additives and caffeine, is targeted at individuals seeking quick hydration, particularly those with active lifestyles, including athletes. Available in multiple flavors, it is positioned as a healthier alternative for boosting hydration and muscle recovery, with a focus on improving both physical and mental well-being.
In July 2024, ChromaDex announced plans to debut its pharmaceutical-grade intravenous Niagen(R) (nicotinamide riboside chloride) at leading wellness clinics starting in August, offering a faster, more effective alternative to traditional NAD+ IV therapies. The new product promises superior tolerability, a shorter infusion time, and a higher rise in NAD+ blood levels, making it a promising innovation in the growing intravenous hydration market.
In April 2024, Liquid I.V., the top powdered hydration brand in the U.S., expanded into the Australian market, offering its Hydration Multiplier to address local hydration challenges. With a strong focus on wellness, the product aims to improve hydration faster than water alone, featuring essential vitamins and electrolytes, and will be manufactured locally to meet growing demand. Unilever's acquisition of Liquid I.V. in 2020 has fueled its international growth, with the product now available in leading Australian retailers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Baxter International
Fresenius Kabi
B. Braun Melsungen AG
Pfizer company
Otsuka Pharmaceutical
Terumo Corporation
Medline Industries
Sagent Pharmaceuticals
Amgen
Vifor Pharma
ICU Medical
Chugai Pharmaceutical
Cipla
Zhejiang Hisun Pharmaceutical
Viatris
Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

Medicated
Non-medicated

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

Immune Boosters
Energy Boosters
Skin Care
Migraine
Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Hospitals
Wellness Centres & Spas
Home Healthcare

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Intravenous (IV) Hydration Therapy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Intravenous (IV) Hydration Therapy Market Snippet by Component
- 2.1.2. Intravenous (IV) Hydration Therapy Market Snippet by Application
- 2.1.3. Intravenous (IV) Hydration Therapy Market Snippet by End-Use
- 2.1.4. Intravenous (IV) Hydration Therapy Market Snippet by Country
- 2.1.5. Intravenous (IV) Hydration Therapy Market Snippet by Region
2.2. Competitive Insights

3. Intravenous (IV) Hydration Therapy Key Market Trends

3.1. Intravenous (IV) Hydration Therapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Intravenous (IV) Hydration Therapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Intravenous (IV) Hydration Therapy Market Opportunities
3.4. Intravenous (IV) Hydration Therapy Market Future Trends

4. Intravenous (IV) Hydration Therapy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Intravenous (IV) Hydration Therapy Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Intravenous (IV) Hydration Therapy Market Landscape

6.1. Intravenous (IV) Hydration Therapy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Intravenous (IV) Hydration Therapy Market - By Component

7.1. Overview
- 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
- 7.1.2. Medicated
- 7.1.3. Non-medicated

8. Intravenous (IV) Hydration Therapy Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Immune Boosters
- 8.1.3. Energy Boosters
- 8.1.4. Skin Care
- 8.1.5. Migraine
- 8.1.6. Others

9. Intravenous (IV) Hydration Therapy Market - By End-Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Wellness Centres & Spas
- 9.1.4. Home Healthcare

10. Intravenous (IV) Hydration Therapy Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Intravenous (IV) Hydration Therapy Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intravenous (IV) Hydration Therapy Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Baxter International
- 11.2.2. Fresenius Kabi
- 11.2.3. B. Braun Melsungen AG
- 11.2.4. Pfizer company
- 11.2.5. Otsuka Pharmaceutical
- 11.2.6. Terumo Corporation
- 11.2.7. Medline Industries
- 11.2.8. Sagent Pharmaceuticals
- 11.2.9. Amgen
- 11.2.10. Vifor Pharma
- 11.2.11. ICU Medical
- 11.2.12. Chugai Pharmaceutical
- 11.2.13. Cipla
- 11.2.14. Zhejiang Hisun Pharmaceutical
- 11.2.15. Viatris
- 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us